Identifying miR-145-3p Regulated Genes in mCRPC
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Chiba University, University of California, San Diego, Teikyo University Chiba Medical Center
Variable analysis
- MiR-145-3p transfection in PC3 cells
- Gene expression profiles in miR-145-3p-transfected PC3 cells compared to mock PC3 cells (log2 ratio < -1.5)
- Genes highly upregulated in metastatic castration-resistant prostate cancer (mCRPC) tissue compared to non-prostate cancer (non-PCa) and hormone-sensitive prostate cancer (HSPC) (fold change > 2, q-value < 0.05)
- Validation of genes upregulated in mCRPC clinical specimens using data from cBioportal and GEO database (GSE 70770)
- Mock PC3 cells (used as control for miR-145-3p transfection)
- Non-prostate cancer (non-PCa) and hormone-sensitive prostate cancer (HSPC) tissues (used as controls for mCRPC tissues)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!